OBLN Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (16 Jun 2021 @ 06:00):

Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity...

Stats
Tagesvolumen	26.47M
Durchschnittsvolumen	1.51M
Marktkapitalisierung	5.47M
EPS	$-0.000410 ( 2021-06-29 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.22
ATR14	$0.665 (21.80%)

Insider Trading

Date	Person	Action	Amount	type
2020-09-16	Stevenson Sharon	Buy	27 250	Stock Option (Right to Buy)
2020-09-16	Stevenson Sharon	Buy	27 250	Stock Option
2020-09-16	Dittamore Raymond V	Buy	27 250	Stock Option
2020-09-16	Dittamore Raymond V	Buy	27 250	Stock Option (Right to Buy)
2020-06-23	Hussainy Nooshin	Buy	165 135	Stock Option (Right to Buy)

INSIDER POWER
0.00
Last 98 transactions
Buy: 7 631 252 \| Sell: 41 791

Volumen Korrelation

Lang: 0.21 (neutral)

Kurz: -0.67 (moderate negative)

Signal:(48.538) Neutral

Obalon Therapeutics Inc Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Obalon Therapeutics Inc Korrelation - Währung/Rohstoff

0.60
( weak )

-0.20
( neutral )

0.00
( neutral )

0.40
( neutral )

-0.54
( weak negative )

-0.69
( moderate negative )

Obalon Therapeutics Inc Finanzdaten

Annual	2020
Umsatz:	$1.59M
Bruttogewinn:	$584 000 (36.78 %)
EPS:	$-1.590

FY	2020
Umsatz:	$1.59M
Bruttogewinn:	$584 000 (36.78 %)
EPS:	$-1.590

FY	2019
Umsatz:	$3.28M
Bruttogewinn:	$331 000 (10.09 %)
EPS:	$-5.03

FY	2018
Umsatz:	$9.10M
Bruttogewinn:	$3.68M (40.41 %)
EPS:	$-19.60

Financial Reports:

No articles found.

Obalon Therapeutics Inc

Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallow able capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. As of February 27, 2020, it had three company-managed retail treatment centers in California. Obalon Therapeutics, Inc. was founded in 2008 and is headquartered in Carlsbad, California.